Skip to main content
PMC home page
Yonsei Medical Journal logoLink to Yonsei Medical Journal
. 2012 Nov 28;54(1):269. doi: 10.3349/ymj.2013.54.1.269

Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.

Minkyu Jung 1,2, Se Hyun Kim 1,2, Soojung Hong 1,2, Young Ae Kang 3, Se Kyu Kim 3, Joon Chang 3, Sun Young Rha 1,2, Joo Hang Kim 1,2, Dae Joon Kim 4, Byoung Chul Cho 1,2
PMCID: PMC3521263  PMID: 23225832

Dear Editor

We deeply regret to inform you that our paper was submitted twice to two different Journals, and was already published in another Journal1; therefore, we are requesting to retract our paper that has been published in YMJ.2 We mistakenly submitted our paper to the other journal. As the corresponding author, I will take full responsibility for this error and respectfully request for the retraction of our paper from YMJ.

References

  • 1.Jung M, Kim SH, Lee YJ, Hong S, Kang YA, Kim SK, et al. Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Exp Ther Med. 2011;2:685–693. doi: 10.3892/etm.2011.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jung M, Kim SH, Hong S, Kang YA, Kim SK, Chang J, et al. Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J. 2012;53:931–939. doi: 10.3349/ymj.2012.53.5.931. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Yonsei Medical Journal are provided here courtesy of Yonsei University College of Medicine

RESOURCES